Medigen Vaccine Biologics Corp.(TW:6547)
NT$46.35-5.15 (-10.00%)
TW:6547
Medigen Vaccine Biologics Corp. ownership
NT$46.35
At close:-5.15 (-10.00%)
Medigen Vaccine Biologics Corp. (6547) Ownership - Who Owns Medigen Vaccine Biologics Corp.?
Medigen Vaccine Biologics Corp. (6547) Ownership Overview
- 2.65% ETFs
- 97.35% Public Companies and Individual Investors
The ownership structure of Medigen Vaccine Biologics Corp. (TW:6547) stock is a mix of institutional, retail, and individual investors. Approximately 2.65% of the company’s stock is owned by Institutional Investors, and 97.35% is owned by Public Companies and Individual Investors.
The ownership structure of Medigen Vaccine Biologics Corp. (TW:6547) stock is a mix of institutional, retail, and individual investors. Approximately 2.65% of the company’s stock is owned by Institutional Investors, and 97.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 8,359,529 | Institution | 2.54% | 11,770,217 |
| State Street | 349,353 | Institution | 0.11% | 491,889 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total International Stock ETF, VXUS ETF | 3,646,336 | Institution | 1.11% | 7,160,106 |
| Vanguard FTSE Emerging Markets ETF, VWO ETF | 3,556,930 | Institution | 1.08% | 6,984,544 |
| Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF | 874,544 | Institution | 0.27% | 1,717,292 |
| Vanguard Total World Stock ETF, VT ETF | 209,287 | Institution | 0.06% | 410,965 |
| SPDR Portfolio Emerging Markets ETF, SPEM ETF | 161,886 | Institution | 0.05% | 252,928 |
| SPDR S&P Emerging Markets Small Cap ETF, EWX ETF | 160,000 | Institution | 0.05% | 249,981 |
| Vanguard ESG International Stock ETF, VSGX ETF | 57,390 | Institution | 0.02% | 89,665 |
| SPDR S&P Emerging Asia Pacific ETF, GMF ETF | 25,467 | Institution | <0.01% | 39,789 |
| Vanguard Funds PLC - Vanguard ESG Emerging Markets All Cap UCITS ETF AccumUSD, DE:V3MA ETF | 4,000 | Institution | <0.01% | 7,842 |
| Vanguard ESG Emerging Markets All Cap UCITS ETF USD, DE:V3ML ETF | 4,000 | Institution | <0.01% | 7,842 |
FAQ
What percentage of Medigen Vaccine Biologics Corp. (TW:6547) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.65% of Medigen Vaccine Biologics Corp. (TW:6547) stock is held by institutional investors.
What percentage of Medigen Vaccine Biologics Corp. (TW:6547) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.35% of Medigen Vaccine Biologics Corp. (TW:6547) stock is held by public companies and individual investors.
Who owns the most shares of Medigen Vaccine Biologics Corp. (TW:6547)?
Vanguard owns the most shares of Medigen Vaccine Biologics Corp. (TW:6547).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
